mRNA PROTACs:用于高效率的向蛋白质降解的工程 PROTACs
Xiaoqi Xue1, Chen Zhang1, Xiaolin Li1
1State Key Laboratory of Chemical Oncogenomics Institute of Biopharmaceutical and Health Engineering Shenzhen International Graduate School, Tsinghua University Shenzhen China.
MedComm
|February 20, 2024
概括
我们开发了针对mRNA蛋白解的嵌合体 (mPROTACs) 来降解标蛋白质. 与类PROTAC相比,这些mPROTACs在降解癌症蛋白质和抑制细胞增殖方面表现出更强的有效性,从而在体内导致显著的瘤回归.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 治疗开发的治疗方法
背景情况:
- 向蛋白质分解的仿真体 (PROTACs) 是用于向蛋白质降解的双功能分子.
- 它们的治疗潜力是显著的,但在很大程度上尚未开发.
- mRNA疗法提供了可扩展性和低成本,为新的 PROTAC 开发提供了机会.
研究的目的:
- 为了设计基于mRNA的PROTACs (mPROTACs) 进行高效的向蛋白质降解.
- 评估mPROTACs对与癌症相关的蛋白质的疗效.
- 为了比较mPROTACs与传统的PROTACs (pPROTACs).
主要方法:
- 通过结合编码von Hippel-Lindau (VHL) 招募和感兴趣的蛋白质 (POI) 结合的mRNA,设计了mPROTACs.
- 进行了针对雌激素受体α和B细胞淋巴瘤超大蛋白的概念验证实验.
- 在小鼠异种移植模型中评估POI降解,细胞增殖抑制和体内瘤回归.
主要成果:
- mPROTACs在各种细胞系中成功降解了标蛋白.
- mPROTACs比pPROTACs更有效地抑制癌细胞增殖.
- 在体内实验中,使用mPROTACs在4T1小鼠异种移植模型中显示出显著的瘤回归.
结论:
- mRNA PROTACs代表了针对性蛋白质降解疗法的新且有前途的策略.
- 与传统的pPROTAC相比,mPROTACs具有更强大的治疗潜力.
- 这种方法对开发新的癌症治疗方法具有重大前景.
相关概念视频
The Proteasome
8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Tagging and Fusion Proteins
6.6K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.6K
Regulated Protein Degradation
7.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
mRNA Stability and Gene Expression
5.6K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
5.6K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Directing Proteins to the Rough Endoplasmic Reticulum
7.3K
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
7.3K


